CClinicalTrials.gg
Active, not recruitingNCT07714226Updated Jul 20, 2026

A Multifaceted Assessment of Eating Behaviors, Anthropometric Measurements and Body Composition in Pediatric Patients With Drug-resistant Epilepsy on a Ketogenic Diet and Healthy Children

An observational study in Epilepsy Intractable, sponsored by Wroclaw Medical University. Active, not recruiting at 2 sites in Poland. Open to participants aged 2 Years to 15 Years, including healthy volunteers. Per ClinicalTrials.gov, last updated 2026-07-20.

Sponsored by Wroclaw Medical University · Observational

Study type
Observational
Model
Case-control
Time perspective
Cross-sectional
Enrollment
150
Ages
2 Years to 15 Years
Sex
All
01

Study summary

The goal of this observational study is to compare the prevalence and severity of eating behaviors-such as food neophobia, picky eating, food fussiness, meal repetition and variety, and food texture preferences-between healthy children and children with drug-resistant epilepsy on a ketogenic diet. It will also compare anthropometric measurements, body composition, and resting metabolic rate (RMR) between the groups. The study seeks to identify key aversive eating behaviors that could potentially affect diet quality.

Participants-children already following the ketogenic diet-will answer questionnaires about eating behaviors and be measured (weight, height, skinfold thickness, and resting metabolic rate). Parents will also answer questionnaires about their children's eating behaviors. Researchers will compare eating behaviors and anthropometric measurements with those of healthy children.

Read the detailed description

It is planned to measure the participants' height and weight. The following measurements will be taken among the study participants: height, using a free-standing, portable Tanita HR-001 (Tanita, Tokyo, Japan) stadiometer, and weight, using a Tanita BC 545 scale (Tanita, Tokyo, Japan). Additionally, the thickness of skinfolds above and below the biceps, below the shoulder blade (subscapular), and above the iliac crest (suprailiac) will be measured. Furthermore, calf, arm, and waist circumferences will be measured.

Based on the data obtained, BMI will be calculated and compared against the OLA and OLAF percentile growth charts dedicated to the Polish pediatric population. As recommended, \<5th percentile will be adopted as underweight, 5th-85th percentile as normal weight, >85th percentile as overweight, and >95th percentile as obesity.

Furthermore, based on body weight, circumference, and skinfold thickness, an assessment of body fat content is planned.

To assess dietary habits, parents and children from both the study and control groups, together with a qualified dietitian, will complete the following questionnaires: the Modified Children's Food Neophobia Scale (Modified CFNS) (parent), the Children's Eating Behavior Questionnaire (CEBQ) (parent), and the Child Food Texture Preference Questionnaire (CFTPQ) (child), translated into Polish.

To supplement information regarding dietary style, the authors will ask parents of children from both the study and control groups additional questions concerning meal variety, meal repetitiveness, and the occurrence of periods of selective eating. The obtained data will be statistically processed and used to create scientific publications.

In addition, resting metabolic rate will be measured in both groups of children using indirect calorimetry. Participants will undergo an approximately 10-minute indirect calorimetry test while fasting and in a supine position, using a COSMED Fitmate WM calorimeter with an age-appropriate breathing mask. The test will be conducted in the presence of a parent.

The obtained RMR results from indirect calorimetry will be compared to standard RMR prediction equations for children, i.e., the Schofield equation, the FAO/WHO equation, and the equations developed by the Institute of Medicine of the National Academies and the Food and Nutrition Board, and expressed as a percentage of their predicted values.

A comparison of results between the control group and the study group is planned. Furthermore, correlation graphs between the studied variables will be created, as well as a PCA (Principal Component Analysis) chart to assess the occurrence of clustered eating habits present in the pediatric population.

02

Conditions studied

  • Epilepsy Intractable

Keywords

  • ketogenic diet
  • drug resistance epilepsy
  • eating behaviours
  • RMR
03

In context

Drug Resistant Epilepsy

261 studies on the registry are indexed under Drug Resistant Epilepsy; 99 are open to participants now.

This study's planned enrollment of 150 is above the median of 88 across 40 observational studies indexed under Drug Resistant Epilepsy.

Browse Drug Resistant Epilepsy studies →

Lead sponsor

Wroclaw Medical University is the lead sponsor of 93 studies on the registry; 28 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
2 Years to 15 Years
Sexes eligible
All
Accepts healthy volunteers
Yes
Sampling method
Non-probability sample

Study population

The entire population of pediatric patients with drug-resistant epilepsy (n=22 individuals) using a ketogenic diet for therapeutic purposes from the only public hospital center in Lower Silesia prescribing this type of treatment, i.e., the T. Marciniak Lower Silesian Specialist Hospital in Wrocław, Poland, was invited to the study group, along with 22 parents or legal guardians of the children.

It was assumed that the control group should reflect the study group in terms of age and place of residence. For this purpose, a matched group of 100 residents of Lower Silesia was created. 50% of them resided in Wrocław (the capital of Lower Silesia; >100,000 inhabitants), and 50% were individuals residing in 16 various localities in Lower Silesia with \<100,000 inhabitants. Each group (n=50), divided by place of residence, included 3 age subgroups, analogous to the age of the study group: younger children - 3-6 years old attending preschool, children from early primary school grades, 7-10 y.

Eligibility criteria

Inclusion Criteria, studied group:

  • consent of the child and guardians/caregivers to participate in the study,
  • diagnosis of drug-resistant epilepsy and use of a ketogenic diet for at least 3 months,
  • age above 2 years, full or partial use of an oral diet (to an extent that allows the child to express their food preferences)
  • possibility of measuring RMR via indirect calorimetry

Exclusion Criteria, studied group :

  • lack of consent from the child and guardians/caregivers to participate in the study
  • non-adherence to ketogenic diet recommendations,
  • 100% nutrition supply via PEG (n=2),
  • age below 2 years (n=2)
  • treatment at a clinical center other than the Lower Silesian one
  • inability to perform anthropometric measurements and RMR

Inclusion Criteria, control group:

  • consent of the parent and child to participate in the study
  • absence of chronic diseases, no permanent use of medications
  • no diagnoses/certificates from a pedagogical-psychological counseling center, e.g., dyslexia, dysgraphia, social relationship disorders, no diagnoses such as Asperger's, Autism, or other spectrum disorders or nervous system function disorders
  • ability to perform anthropometric measurements
  • Polish citizenship and residence in Poland
  • residence in the Lower Silesia region.

Exclusion Criteria, control group:

  • lack of consent to perform/participate in the study
  • chronic diseases including neurological disorders, certificates and/or diagnoses from a psychological-pedagogical counseling center
  • use of specialized diets related to illness or exclusion diets (vegetarian, vegan, ketogenic diet)
  • chronic use of medications related to illness, inability to perform anthropometric measurements and RMR meaurements.
05

Study design

Observational model
Case-control
Time perspective
Cross-sectional
Enrollment
150 participants (estimated)
Patient registry
No

Groups and cohorts

  • Study group - children with drug-resistant epilepsy on a ketogenic diet
  • Control group - healthy children on a standard diet
06

What researchers measure

Primary outcomes

  1. Comparison of frequency and severity of food neophobia between groups, based on the Modified CFNS.

    For Modified Children's Food Neophobia Scale (Modified CFNS) the following cut-off values were adopted to indicate the presence and/or severity of neophobia: * Values \>12 points were considered indicative of a higher degree of food neophobia, and ≤12 points as a lower level of food neophobia. Following other authors, values above M+1SD were adopted as indicative of neophobia. The mean score values, as well as the percentages of children presenting higher and lower food neophobia, will be compared between groups.

    Time frame: from enrollment to the end of data collection (03.2026)

  2. Differences in resting metabolic rate values between healthy children and children on a ketogenic diet, based on indirect calorimetry and the percentage of predicted values according to theoretical RMR prediction equations

    The obtained RMR results from indirect calorimetry will be compared to standard RMR prediction equations for children, i.e., the Schofield equation, the FAO/WHO equation, and the equations developed by the Institute of Medicine of the National Academies and the Food and Nutrition Board, and expressed and compare as a percentage of their predicted values.

    Time frame: From enrollment to the end of data collection (03/2026)

  3. Comparison of frequency and severity of eating difficulties between groups, based on CEBQ.

    In Children's Eating Behavior Questionnaire (CEBQ) - the following cut-off values were adopted to indicate the presence and/or severity of eating behaviors: Score levels above 50% of a given subscale were assessed as indicating a higher representation of the corresponding eating style. Results above M±SD were set as indicating a strong representation of a given eating style among children. The frequency and severity of presented habits assessed in the questionnaire will be compared between groups.

    Time frame: from enrollment to the end of data collection (03.2026)

  4. Comparison of children's food texture preferences between groups, based on the CFTPQ.

    Based on results from The Child Food Texture Preference Questionnaire (CFTPQ) - Scores \<25th percentile classified children into the so-called "soft texture likers" group, while scores \>75th percentile classified children into the "hard texture likers" group. The percentages of children classified as so-called 'soft texture likers' and 'hard texture likers' will be compared between groups.

    Time frame: from enrollment to the end of data collection (03.2026)

Secondary outcomes

  1. Comparison of the nutritional status of the study group and the control group based on percentile values for height, weight, and BMI.

    Body weight (kg) and height (cm) values will be compared against percentile charts for the Polish population, and the resulting percentiles will be compared between groups. In addition, the data obtained will be expressed as the BMI index (kg/m²), which will likewise be compared against percentile charts, with the resulting percentiles then compared between groups. For weight and BMI percentile values: \<5th percentile will be adopted as underweight, 5th-85th percentile as normal weight, \>85th percentile as overweight, and \>95th percentile as obesity. Height percentiles will be divided into \<5th percentile, indicating insufficient height, and values above this threshold, indicating adequate height.

    Time frame: from enrollment to the end of data collection (03.2026)

  2. Comparison of percentage body fat content, based on skinfold thickness measurements, between the study group and the control group.

    Based on skinfold thickness measurements (triceps and subscapular, expressed in mm), the percentage body fat content will be estimated using the Slaughter equation, and the resulting mean values will be compared between groups.

    Time frame: From enrollment to the end of data collection (03/2026)

07

Study locations

2 sites
  • Dolnośląski Szpital Specjalistyczny im. T.Marciniaka
    Wroclaw, Lower Silesian Voivodeship, Poland
  • Wroclaw Medical University - Pharmacy Faculty
    Wroclaw, Lower Silesian Voivodeship, Poland
08

References and documents

Publications

  • Gutierrez Martin M, Gomez Casal F. [Nitroblue-tetrazolium reduction and peroxidase activity in normal leukocytes (author's transl)]. Folia Clin Int (Barc). 1974 Mar;24(3):225-37. No abstract available. Spanish. PubMed 4133288 ↗
  • M. Laureati, P. Sandvik, V. L. Almli, M. Sandell, G.G. Zeinstra, L. Methven, M. Wallner, H. Jilani, B. Alfaro, C. Proserpio, Individual differences in texture preferences among European children: Development and validation of the Child Food Texture Preference Questionnaire (CFTPQ),Food Quality and Preference, Volume 80,2020,103828, https://doi.org/10.1016/j.foodqual.2019.103828.
  • Damsbo-Svendsen M, Frost MB, Olsen A. A review of instruments developed to measure food neophobia. Appetite. 2017 Jun 1;113:358-367. doi: 10.1016/j.appet.2017.02.032. Epub 2017 Mar 6. PubMed 28268200 ↗
  • Wardle J, Guthrie CA, Sanderson S, Rapoport L. Development of the Children's Eating Behaviour Questionnaire. J Child Psychol Psychiatry. 2001 Oct;42(7):963-70. doi: 10.1111/1469-7610.00792. PubMed 11693591 ↗
  • Malczyk Z, Kuczka O, Pasztak-Opilka A, Zachurzok A. Validation of the Children's Eating Behaviour Questionnaire in Poland. Nutrients. 2022 Nov 11;14(22):4782. doi: 10.3390/nu14224782. PubMed 36432467 ↗
  • Ferraris C, Guglielmetti M, Pasca L, De Giorgis V, Ferraro OE, Brambilla I, Leone A, De Amicis R, Bertoli S, Veggiotti P, Tagliabue A. Impact of the Ketogenic Diet on Linear Growth in Children: A Single-Center Retrospective Analysis of 34 Cases. Nutrients. 2019 Jun 26;11(7):1442. doi: 10.3390/nu11071442. PubMed 31247999 ↗
  • Kossoff EH, Zupec-Kania BA, Auvin S, Ballaban-Gil KR, Christina Bergqvist AG, Blackford R, Buchhalter JR, Caraballo RH, Cross JH, Dahlin MG, Donner EJ, Guzel O, Jehle RS, Klepper J, Kang HC, Lambrechts DA, Liu YMC, Nathan JK, Nordli DR Jr, Pfeifer HH, Rho JM, Scheffer IE, Sharma S, Stafstrom CE, Thiele EA, Turner Z, Vaccarezza MM, van der Louw EJTM, Veggiotti P, Wheless JW, Wirrell EC; Charlie Foundation; Matthew's Friends; Practice Committee of the Child Neurology Society. Optimal clinical management of children receiving dietary therapies for epilepsy: Updated recommendations of the International Ketogenic Diet Study Group. Epilepsia Open. 2018 May 21;3(2):175-192. doi: 10.1002/epi4.12225. eCollection 2018 Jun. PubMed 29881797 ↗

Study documents

  • Informed consent form · Jun 1, 2026
  • Informed consent form · Jun 1, 2026

Documents are hosted by the registry — open the source record to download them.

Individual participant data

Plan to share: Undecided

09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Jul 20, 2026, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT07714226
Lead sponsor
Wroclaw Medical University
Responsible party
Sponsor
First posted
Jul 20, 2026
Start date
Apr 12, 2023
Primary completion
Dec 12, 2026 (estimated)
Completion
Dec 12, 2027 (estimated)
Last update
Jul 20, 2026

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is active, not recruiting, as verified in Jun 2026. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion